» Articles » PMID: 39200809

Clinical Impact of Intracoronary Imaging in the Management of Stent Thrombosis

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Aug 29
PMID 39200809
Authors
Affiliations
Soon will be listed here.
Abstract

Use of intracoronary imaging (ICI) in cases of stent thrombosis (ST) is recommended and tailored treatment appears reasonable. Nevertheless, data supporting such a strategy are lacking. The aim of this study was to evaluate the clinical impact of ICI in the management of ST. The unadjusted study population was consecutive patients with definite ST presenting in a single tertiary cardiac centre and undergoing percutaneous coronary intervention (PCI). The presumed major mechanism of ST was assigned according to the real-time ICI interpretation by the PCI operator. Propensity score matching was performed with regard to ICI use to form the adjusted population and Kaplan-Meier analysis was applied to compare survival free of cardiac death (CD) or target lesion revascularization (TLR). The unadjusted population included 130 ST patients, with the majority presenting with ST-elevation myocardial infarction (STEMI) (88%) and very late ST (86%). ICI was performed in 45 patients, of whom optical coherence tomography (OCT) was performed in 30 cases. When the individual ST mechanisms were viewed as groups, there was an interaction observed between type of treatment (stent vs. non-stent) and ST mechanism, with non-stent treatment being more prevalent in cases of underexpansion, malapposition, in-stent restenosis and mechanism uncertainty. After application of matching, two groups of 30 patients were formed. ICI-guided management resulted in better survival free of CD-TLR at 2 years (93% vs. 73%, = 0.037). Intracoronary imaging guidance during PCI for ST had a direct impact on management (stent vs. non-stent) and resulted in a lower event rate at mid-term follow-up when propensity matched analysis was applied.

Citing Articles

Platelets, Biomarkers of Coagulation and Fibrinolysis, and Early Coronary Stent Thrombosis.

Galli L, Sator A, Schauer S, Brau K, Bernhard J, Hengstenberg C J Clin Med. 2025; 14(1.

PMID: 39797139 PMC: 11721602. DOI: 10.3390/jcm14010056.

References
1.
Adriaenssens T, Joner M, Godschalk T, Malik N, Alfonso F, Xhepa E . Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation. 2017; 136(11):1007-1021. PMC: 5598909. DOI: 10.1161/CIRCULATIONAHA.117.026788. View

2.
Stefanini G, Alfonso F, Barbato E, Byrne R, Capodanno D, Colleran R . Management of myocardial revascularisation failure: an expert consensus document of the EAPCI. EuroIntervention. 2020; 16(11):e875-e890. DOI: 10.4244/EIJ-D-20-00487. View

3.
Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G . Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016; 37(15):1208-16. DOI: 10.1093/eurheartj/ehv711. View

4.
Byrne R, Joner M, Kastrati A . Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015; 36(47):3320-31. PMC: 4677274. DOI: 10.1093/eurheartj/ehv511. View

5.
Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H . Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012; 5(1):12-20. DOI: 10.1016/j.jcin.2011.09.018. View